Detection and characterization of circulating tumor cells by the CellSearch approach

Methods in Molecular Biology

Volumn 1347, Issue , 2015, Pages 263-278

  Coumans, Frank ^a   Terstappen, Leon ^a  

^a NONE

Author keywords

CTC; CTC assignment; Ferrofluids; Fluorescent labeling; Fluorescent microscopy; Image analysis; Immunomagnetic enrichment

Indexed keywords

FLUORESCENT DYE;

BLOOD SAMPLING; CANCER PATIENT; CANCER SURVIVAL; CIRCULATING TUMOR CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; METASTASIS; SINGLE CELL ANALYSIS;

EID: 84941928093     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2990-0_18     Document Type: Chapter

References (17)

1. Terstappen LWMM, Rao C, Gross S, Kotelnikov V, Racila E, Uhr J, Weiss A (1998) Enumeration of epithelial derived tumor cells in peripheral blood. Vox Sanguinis 74:269–274
2. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LWMM, Uhr JW (1998) Detection and characterization of carcinoma cells in the blood. PNAS 95:4589–4594
3. Terstappen LWMM, Rao C, Gross S, Weiss A (2000) Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast. Int J Oncol 17: 573–578
4. Moreno JG, O’Hara SM, Gross S, Doyle G, Fritsche H, Gomella LG, Terstappen LWMM (2001) Changes in circulating carcinoma cells in metastatic prostate cancer patients correlates with disease status. Urology 58:386–392
5. Hayes DF, Walker TM, Singh B, Vitetta ES, Uhr JW, Gross S, Rao C, Doyle GV, Terstappen LWMM (2002) Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol 21:1111–1118
6. Liberi PA, Rao CG, Terstappen LWMM (2001) Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magn Magn Mater 225:301–307
7. Kagan M, Howard D, Bendele T, Mayes J, Silvia J, Repollet M, Doyle J, Allard J, Tu N, Bui T, Russell T, Rao C, Hermann M, Rutner H, Terstappen LWMM (2002) A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 25:104
8. Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA, Terstappen LWMM (2005) Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol 27:49–58
9. Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O’Hara SM, Russell T, Terstappen LWMM (2004) Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry 62A:46–53
10. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe A, Uhr JW, Terstappen LWMM (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases. Clin Can Res 10:6897–6904
11. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Rueben JM, Doyle G, Allard WJ, Terstappen LWMM, Hayes DF (2004) Circulating tumor cells, disease progression and survival in metastatic breast cancer. NEJM 351:781–791
12. Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Desch CE, Miller MC, Doyle GV, Tissing H, Terstappen LWMM, Meropol NJ (2008) The relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26: 3213–3221
13. DeBono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LWWM, Pienta KJ, Raghavan D (2008) Circulating tumor cells (CTC) predictsurvival benefit from treatment in metastatic castration resistant prostate cancer (CRPC). Clin Can Res 14:6302–6309
14. Miller MC, Doyle GV, Terstappen LWMM (2009) Significance of circulating tumor cells detected by the CellSearch® system in patients with metastatic breast colorectal and prostate cancer. J Oncol 1–8, Article ID 617421
15. Coumans F, Doggen CJM, Attard G, de Bono JS, Terstappen LWMM (2010) All circulating EpCAM + CD45-CK+ but not EpCAM +CD45 + CK+ objects predict overall survival incastration-resistant prostate cancer. Ann Oncol 21:1851–1857
16. Tibbe AGJ, de Grooth BG, Greve J, Dolan GJ, Rao C, Terstappen LWMM (2002) Magnetic field design for selecting and aligning immunomagnetic labeled cells. Cytometry 47: 163–172
17. Tibbe AGJ, Miller C, Terstappen LWMM (2007) Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71A:154–162